Aurobindo Pharma USA, Inc., has issued another voluntary recall of medications used to treat high blood pressure and heart failure due to the possible presence of a cancer-causing substance in the ...

The FDA has announced two added recalls of blood pressure medication tainted with a cancer-causing impurity. Legacy Pharmaceutical Packaging, LLC issued a voluntary nationwide recall of Losartan ...

A recall of Losartan potassium tablets that could contain a cancer-causing impurity was expanded Thursday to include more lots. It's the second recall of its kind this week and one of several since ...

In the ongoing saga of contaminated sartans, a new nitrosamine impurity has been detected in certain lots of recalled losartan products, the US Food and Drug Administration (FDA) has announced. A ...

Indian drugmakers Aurobindo, Glenmark and Zydus have issued separate sweeping drug recalls over issues pertaining to impurities and labeling. The product pulls were reported in a recent edition of the ...